Skip to main content
SpringerLink
Log in

Paring down the company: the effect of consolidation in the European biotech sector

  • Careers and Recruitment
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

The current economic downturn has led biotechs to alter their business models and shape new roles for management and investors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. The author is at Korn/Ferry International, 123 Buckingham Palace Road, London, SW1W 9DZ, UK

    Peter Bassett

Authors
  1. Peter Bassett
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bassett, P. Paring down the company: the effect of consolidation in the European biotech sector. Nat Biotechnol 21, 829–830 (2003). https://doi.org/10.1038/nbt0703-831

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0703-831

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation